Clinical Trials Directory

Trials / Completed

CompletedNCT00975910

Effect of Lidocaine in Antiarrhythmic Dosage on Postoperative Cognitive Dysfunction in Supratentorial Craniotomy Dysfunction in Supratentorial Craniotomy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the effect of lidocaine in antiarrhythmic dosage on postoperative cognitive dysfunction in supratentorial craniotomy.

Conditions

Interventions

TypeNameDescription
DRUGlidocaineLidocaine arm: lidocaine (2%) as an intravenous bolus (1.5 mg/kg) during induction followed by an intravenous infusion (2 mg. kg(-1).h(-1)) after induction until at the end of surgery
DRUGsalineSaline arm: infused at the same rate as lidocaine

Timeline

Start date
2009-09-01
Primary completion
2012-05-01
Completion
2012-12-01
First posted
2009-09-14
Last updated
2013-05-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00975910. Inclusion in this directory is not an endorsement.

Effect of Lidocaine in Antiarrhythmic Dosage on Postoperative Cognitive Dysfunction in Supratentorial Craniotomy Dysfunc (NCT00975910) · Clinical Trials Directory